| abstract |
Improved system for targeted enzyme prodrug therapy, particularly antibody-directed enzyme prodrug therapy (ADEPT), wherein the enzyme used is a mutated form of the host enzyme, wherein the native host enzyme, such as a nuclease, is mediated by ion pairing The interaction between the mutant enzyme and the complementary prodrug can reverse ("reverse the polarity") said interaction. |